Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Nahon

Showing results (111-120 of 205) with videos related to

Pageof 21
Sort By:
Oncotarget|February 22, 2018
Determination of candidate metabolite biomarkers associated with recurrence of HCV-related hepatocellular carcinomaZhicheng Liu, Pierre Nahon, Zaifang Li, et al.
Cancer Research|March 3, 2006
Genetic polymorphisms in antioxidant enzymes modulate hepatic iron accumulation and hepatocellular carcinoma development in patients with alcohol-induced cirrhosisAngela Sutton, Pierre Nahon, Dominique Pessayre, et al.
Gastroenterology|December 7, 2007
Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosisPierre Nahon, Angela Sutton, Pierre Rufat, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 5, 2023
Atezolizumab plus bevacizumab in advanced hepatocellular carcinoma after treatment failure with multikinase inhibitorsVincent Haghnejad, Marie Muller, Lorraine Blaise, et al.
Clinics and Research in Hepatology and Gastroenterology|May 19, 2020
Prior surveillance and antiviral treatment improve the prognosis of HCC developed in HBV patients in the WestManon Allaire, Weam El Hajj, Ségolène Brichler, et al.
Annals of Emergency Medicine|February 22, 2011
Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trialDominique Pateron, Eric Vicaut, Erwan Debuc, et al.
Journal of Proteome Research|March 26, 2016
Sequential Serum Metabolomic Profiling after Radiofrequency Ablation of Hepatocellular Carcinoma Reveals Different Response Patterns According to EtiologyCorentine Goossens, Pierre Nahon, Laurence Le Moyec, et al.
Journal of Hepatology|April 23, 2014
Impact of cytokine gene variants on the prediction and prognosis of hepatocellular carcinoma in patients with cirrhosisArige Tarhuni, Erwan Guyot, Pierre Rufat, et al.
Journal of Hepatology|February 9, 2022
HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysisAmit G Singal, Emily Zhang, Manasa Narasimman, et al.
Journal of Hepatology|June 28, 2011
Survival after radiofrequency ablation and salvage transplantation in patients with hepatocellular carcinoma and Child-Pugh A cirrhosisGisèle N'Kontchou, Mounir Aout, Alexis Laurent, et al.
Pageof 21

Showing results (111-120 of 205) with videos related to

Sort By:
Pageof 21
Oncotarget|February 22, 2018
Determination of candidate metabolite biomarkers associated with recurrence of HCV-related hepatocellular carcinomaZhicheng Liu, Pierre Nahon, Zaifang Li, et al.
Cancer Research|March 3, 2006
Genetic polymorphisms in antioxidant enzymes modulate hepatic iron accumulation and hepatocellular carcinoma development in patients with alcohol-induced cirrhosisAngela Sutton, Pierre Nahon, Dominique Pessayre, et al.
Gastroenterology|December 7, 2007
Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosisPierre Nahon, Angela Sutton, Pierre Rufat, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 5, 2023
Atezolizumab plus bevacizumab in advanced hepatocellular carcinoma after treatment failure with multikinase inhibitorsVincent Haghnejad, Marie Muller, Lorraine Blaise, et al.
Clinics and Research in Hepatology and Gastroenterology|May 19, 2020
Prior surveillance and antiviral treatment improve the prognosis of HCC developed in HBV patients in the WestManon Allaire, Weam El Hajj, Ségolène Brichler, et al.
Annals of Emergency Medicine|February 22, 2011
Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trialDominique Pateron, Eric Vicaut, Erwan Debuc, et al.
Journal of Proteome Research|March 26, 2016
Sequential Serum Metabolomic Profiling after Radiofrequency Ablation of Hepatocellular Carcinoma Reveals Different Response Patterns According to EtiologyCorentine Goossens, Pierre Nahon, Laurence Le Moyec, et al.
Journal of Hepatology|April 23, 2014
Impact of cytokine gene variants on the prediction and prognosis of hepatocellular carcinoma in patients with cirrhosisArige Tarhuni, Erwan Guyot, Pierre Rufat, et al.
Journal of Hepatology|February 9, 2022
HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysisAmit G Singal, Emily Zhang, Manasa Narasimman, et al.
Journal of Hepatology|June 28, 2011
Survival after radiofrequency ablation and salvage transplantation in patients with hepatocellular carcinoma and Child-Pugh A cirrhosisGisèle N'Kontchou, Mounir Aout, Alexis Laurent, et al.
Pageof 21